Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
SOMERSET, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, March 10, 2026, to review fourth-quarter and full-year 2025 financial results.
During the conference call and accompanying webcast, senior management will provide an overview of quarterly and full-year financial performance.
With over 2,900 employees, Legend Biotech is the largest standalone cell therapy company and a pioneer in treatments that change cancer care forever. The company is at the forefront of the CAR-T cell therapy revolution with CARVYKTI
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
InitVerse Joins UXLINK to Combine AI Web3 Framework with Social Growth
Why is Injective (INJ) Price Surging Today?
Quantum Computing Threat 'Mostly a Coordination Issue' for Bitcoin: Fireblocks CEO
